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Background:Mercaptopyruvate sulfurtransferase (MST) generates H2S, a signaling molecule.
Results: The detailed kinetics and crystal structure of human MST with bound substrate are reported.
Conclusion: Thioredoxin is the preferred persulfide acceptor fromMST.
Significance: The structure provides molecular insights into activation and stabilization of MST reaction intermediates.
Mercaptopyruvate sulfurtransferase (MST) is a source of
endogenous H2S, a gaseous signaling molecule implicated in a
wide range of physiological processes. The contribution ofMST
versus the other two H2S generators, cystathionine -synthase
and-cystathionase, has beendifficult to evaluate becausemany
studies on MST have been conducted at high pH and have used
varied reaction conditions. In this study, we have expressed,
purified, and crystallized human MST in the presence of the
substrate 3-mercaptopyruvate (3-MP). The kinetics of H2S pro-
duction by MST from 3-MP was studied at pH 7.4 in the pres-
ence of various physiological persulfide acceptors: cysteine,
dihydrolipoic acid, glutathione, homocysteine, and thioredoxin,
andinthepresenceofcyanide.Thecrystal structureofMSTreveals
a mixture of the product complex containing pyruvate and an
active site cysteine persulfide (Cys248-SSH) and a nonproductive
intermediate in which 3-MP is covalently linked via a disulfide
bond to anactive site cysteine.The crystal structure analysis allows
us to propose a detailedmechanism forMST inwhich anAsp-His-
Ser catalytic triad ispositioned toactivate thenucleophilic cysteine
residueandparticipate ingeneralacid-basechemistry,whereasour
kinetic analysis indicates that thioredoxin is likely to be the major
physiological persulfide acceptor forMST.
Since the first report of the role of H2S as a possible endoge-
nous neuromodulator (1), H2S has rapidly emerged as a signal-
ing molecule impacting a broad range of physiological func-
tions (2–6). The low steady-state concentration of H2S in
tissues, estimated to be in the 10–30 nM range (7–9), is a prod-
uct of both its biogenesis and clearance rates (8). H2S is pro-
duced by the transsulfuration pathway enzymes, cystathionine
-synthase and -cystathionase, which are cytosolic and by
3-mercaptopyruvate sulfurtransferase (MST),2 which is local-
ized in the cytoplasm and themitochondrion (10–13). Detailed
steady-state (14, 15) and pre-steady (16, 17) kinetic studies on
cystathione -synthase and -cystathionase enzymes at physi-
ological pH have provided insights into the efficiency of the
various H2S-generating reactions that they catalyze. In con-
trast, studies on human MST have lagged behind. This,
together with a number of earlier studies onMST from various
mammalian sources that were conducted at high pH and varied
reaction conditions, have made it difficult to compare the
kinetics of H2S generation by MST versus the transsulfuration
pathway enzymes.
MST is expressed predominantly in kidney cells, liver cells,
cardiac cells, proximal tubular epithelium, pericentral hepato-
cytes, and neuroglial cells (13).Mutations in theMST gene lead
to mercaptolactate-cysteine disulfiduria, an inborn error of
metabolism (18). Recent studies support the role of MST as a
potentially important generator of H2S in some organisms and
tissues (19–22). In the MST-dependent route for H2S genera-
tion, cysteine is converted via the action of aspartate (or cys-
teine) aminotransferase, to 3-MP, which is acted upon byMST
to give pyruvate and an enzyme-bound persulfide (Fig. 1, a and
b). The MST-bound persulfide can be transferred to an accep-
tor such as cyanide to generate a less toxic product, thiocyanate
(23). Alternatively, H2S can be released from the MST-bound
persulfide in the presence of a reducing system. Examples of
nonphysiological reductants that can liberate H2S includeDTT
(21, 24) and 2-mercaptoethanol (23). The potential for physio-
logically relevant small molecule thiols such as GSH, homocys-
teine, and cysteine, to couple withMST, has not been evaluated
in a kinetically defined system. Thioredoxin in the presence of
thioredoxin reductase and NADPH, or dihydrolipoic acid
(DHLA), are examples of physiologically relevant reducing sys-
tems that can release H2S fromMST-bound persulfide (19, 25).
Trypanosomal variants ofMST have a C-terminal thioredoxin-
like domain, suggesting that thioredoxin might be a physiolog-
ically relevant partner of MST in other organisms as well (23,
26).
MST is a member of the sulfurtransferase family; it shares
60% sequence similarity with rhodanese (also known as thio-
sulfate sulfurtransferase), a prototypic member of this family.
Both proteins have a conserved active site architecture with a
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catalytic cysteine residue, reflecting a common evolutionary
origin (27). In ratMST,Cys247 is predicted to be the nucleophile
that is persulfidated upon sulfur transfer from 3-MP (28). Two
arginine residues are proposed to interact with the carbonyl
oxygen and the carboxylate group of 3-MP and are important
determinants of MST specificity for 3-MP versus thiosulfate
(28).
In the present study, we report the purification of human
MST and the kinetic analysis of H2S production in the presence
of a range of physiologically relevant and artificial acceptors.
We also report the first crystal structure of human MST that
contains a mixture of a product complex (Cys248-SSH  pyru-
vate) and an intermediate, 3-MP linked to an active site cysteine
via a disulfide bond. Our results allow us to propose a detailed
reactionmechanism forMST inwhich a catalytic triad could be
involved in activating the active site nucleophile (Cys248) and
facilitating the reaction via general acid-base chemistry.
EXPERIMENTAL PROCEDURES
Materials
The sodium salt of 3-MP was purchased from Research
Organics (Cleveland, OH). L-cysteine, DL-homocysteine, DTT,
GSH, 2-mercaptoethanol, and NADPH were purchased from
Sigma-Aldrich. DHLA was purchased from Santa Cruz Bio-
technology (Dallas, TX).
Cloning of Human MST
Human MST cDNA cloned in the pOTB7 vector (ATCC
number MGC-10492) was purchased from ATCC (Manassas,
VA). The MST cDNA was PCR-amplified using Pfu ultra
high fidelity DNA polymerase and the following primers:
5-TACAGACATATGGTGTCGGCGCAATGG-3 (forward)
and 5-CAACCGAAGCTTTCAGATGACATCCTCGGGC-3
(reverse). The PCR product was subcloned into the pET28b
Vector (Novagen) using NdeI and HindIII to generate the
expression construct pET28b_hMST.
Expression and Purification of Human Thioredoxin and
Thioredoxin Reductase
Expression constructs for human thioredoxin (cytoplasmic)
and thioredoxin reductase were a generous gift fromDr. Vadim
Gladyshev (Harvard Medical School). The cDNAs were
expressed in Escherichia coli and purified as described previ-
ously (29, 30).
Expression and Purification of MST
The pET28b_hMST plasmid was co-transformed with the
pTrc99A-EL plasmid harboring genes for the molecular chap-
erones GroES/GroEL, in E. coli BL21 (DE3). The transformed
cells were grown overnight at 28 °C in 200 ml of Luria Bertani
medium containing kanamycin (60 g/ml) and ampicillin (100
g/ml). The following day, six 1-liter volumes of Luria Bertani
medium containing the same antibiotics were inoculated with
the starter culture and grown at 28 °C (240 rpm). After 3 h, the
temperature was reduced to 15 °C, and growth was continued
until A600 reached 0.6. The cultures were induced with 100 M
isopropyl -D-thiogalactopyranoside, and the cells were har-
vested 18 h later. The cells pellets were stored at 80 °C until
use.
The cell pellets were suspended in 250 ml of 50 mM sodium
phosphate buffer, pH 7.5, containing 500 mM NaCl, lysozyme
(100 mg), MgCl2 (5 mM), DNase (10 mg), single protease inhib-
itor mixture tablet (Roche Applied Science), and 500 M tris(2-
carboxyethyl)phosphine. The cell suspensionwas stirred at 4 °C
for 40min and then sonicated (power setting 7) for 10min at
30-s intervals separated by 1-min cooling periods. The sonicate
was centrifuged at 38,000  g for 20 min, and the supernatant
was loaded on to a nickel-nitrilotriacetic acid-agarose column
(2.5  10 cm) pre-equilibrated with sodium phosphate buffer,
pH 7.5, containing 500 mM NaCl and 20 mM imidazole. The
column was washed with 300 ml of equilibration buffer con-
taining 40 mM imidazole and eluted with 500 ml of a linear
gradient ranging from40 to 250mM imidazole in 50mM sodium
phosphate buffer, pH 7.5, containing 500 mM NaCl. The frac-
tions containing MST were identified following SDS-PAGE
analysis, pooled, and concentrated to 10 ml and dialyzed
overnight against 2 liters of 50 mM Tris buffer, pH 8.0. The
dialyzed protein was loaded on to a DEAE-Sepharose column
(2.5  15 cm) preequilibrated with 50 mM Tris buffer, pH 8.0.
The column was washed with 200 ml of the buffer, and the
proteinwas elutedwith a 500-ml gradient ranging from0 to 500
mM NaCl in the same buffer. The fractions of interest were
concentrated and stored at 80 °C.
Estimation of the Molecular Mass of MST
PurifiedMSTwith anN-terminalHis6 tagwas separated on a
prepackedHiload 16/60 Superdex 200 column (GEHealthcare)
with a flow rate of 0.5mlmin1 in 50mMTris buffer, pH 8. The
parent ion mass of MST (after purification by size exclusion
chromatography) was determined by electrospray ionization
mass spectrometry using a Q-Star XL Hybrid MS/MS mass
spectrometer (Proteomics and Metabolomics Core Facility,
Redox Biology Center, University of Nebraska, Lincoln).
FIGURE 1. Reactions leading to H2S generation via the CAT/MST pathway.
a, CAT catalyzes the transamination between cysteine and -ketoglutarate to
mercaptopyruvate and glutamate, respectively. b, MST catalyzes the sulfur
transfer from 3-MP to an active site cysteine, giving pyruvate and MST-bound
persulfide. c, MST-bound persulfide reacts with thiols or thioredoxin (in pres-
ence of NADPH/thioredoxin reductase) to generate H2S.
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MST Activity Assays
The following assays were used to determine MST activity.
One unit of activity is defined as formation of 1mol of product
min1 mg1 of protein at 37 °C. The Km and Vmax values were
obtained by fitting the data sets to either theMichaelis-Menten
or the Hill equation.
Activity Based on H2S Production—H2S formed by the reac-
tion of 3-MP and reductants (2-mercaptoethanol, DTT,DHLA,
L-cysteine, L-homocysteine, and GSH) was determined in the
lead sulfide assay (15, 23). The reactionmixture containing 200
mM HEPES buffer, pH 7.4, 0.4 mM lead nitrate, BSA (100
g/ml), 0.3 mM 3-MP, and 20mM reductants was preincubated
at 37 °C for 4min, and the reactionwas initiated by the addition
of purified MST. Continuous formation of lead sulfide was
monitored spectrophotometrically at 390 nm, and a molar
extinction coefficient of 5,500 M1 cm1 for lead sulfide was
used to determine its concentration (14). TheKm values for the
reductants were determined in the presence of 0.3 mM 3-MP
and the following co-substrate concentrations: DTT (0–20
mM), DHLA (0–20 mM), L-cysteine (0–14 mM), L-homocys-
teine (0–70mM), andGSH (0–100mM). TheKm for-mercap-
toethanol (0–300 mM) was determined in the presence of 0.5
mM 3-MP.
Activity Based on Thiocyanate Formation—Thiocyanate for-
mation was monitored as described previously (23) with the
following modifications. Briefly, 1 ml of the reaction mixture
containing 200 mM HEPES buffer, pH 7.4, 3-MP (5 mM), KCN
(25 mM), and bovine serum albumin (100 g/ml) was preincu-
bated at 37 °C for 4min. The reaction was initiated by the addi-
tion of MST, and incubation was continued at 37 °C for 5 min.
The reaction was stopped by the addition of 500 l of formal-
dehyde, and 1.5ml of the iron reagent (Fe(NO3)3, 50 g/liter; and
65%HNO3, 200 ml/liter) were added to detect FeSCN forma-
tion at 460 nm. The Km for KCN was determined in the pres-
ence 5 mM 3-MP and 0–25 mM KCN. The Km for 3-MP was
determined in the presence of 25 mM KCN and 0–2 mM 3-MP.
Thioredoxin-dependent Sulfurtransferase Activity—Oxida-
tion of NADPH in a coupled MST-thioredoxin/thioredoxin
reductase assay was measured as described previously (26).
Briefly, a 1-ml reaction mixture containing 200 mM HEPES
buffer, pH 7.4, 200 M NADPH, 3.5 M thioredoxin reductase,
20 M thioredoxin, BSA (100 g), and 3-MP (0–3 mM) was
preincubated for 4 min at 37 °C. The reaction was started by
addition of 0.3 MMST, and the rate of NADPH oxidation was
monitored at 340nmusing the extinction coefficient, 6,220M1
cm1. Generation of H2S under these conditions (Fig. 1c) was
monitored by the addition of 0.4mM lead nitrate to the reaction
mixture and detecting the increase in A390.
Determination of the pH Dependence of MST Activity
The pH dependence of MST was determined in the lead sul-
fide assay in the presence of 2-mercaptoethanol (50 mM) as
described above. The following bufferswere used: 200mMcitric
acid-sodium citrate buffer (pH 4.5–6.5), HEPES buffer (pH
6.5–8.3), and boric acid-sodium borate buffer (pH 8.2–10.5).
The data were fitted using a Gaussian function (Sigma-Plot 10).
Crystallization and Crystal Harvesting
Stock solutions of 9mg/ml of truncatedMST (t-MST,N10,
and C8) in 50 mM HEPES, 100 mM NaCl, and 5% v/v glycerol
were used for crystallization trials. Crystals of t-MST were
obtained at 20 °C in 2weeks by the vapor diffusionmethod from
1:1 mixtures of protein and reservoir solution in sitting drop
plates. The reservoir solution contained 2M ammonium sulfate,
0.1 M sodium acetate, pH 4.5, and 0.02 M betaine hydrochloride.
Crystals of 3-MP bound to t-MST were obtained by soaking.
Specifically, crystals of apo t-MST were transferred to a solu-
tion containing 2 M ammonium sulfate, 0.1 M sodium acetate,
pH 4.5, 0.02 M betaine hydrochloride, 2 mM 3-MP, and 25% v/v
glycerol. After 2 h of soaking, the crystals were harvested and
were flash frozen in liquidN2.Crystals of 3-MPbound to t-MST
were of space group C2 (a  110.7 Å, b  171.8 Å, c  73.0 Å)
with three molecules in the asymmetric unit (Matthews’ coef-
ficient VM  3.1 Å3/Da for three molecules per asymmetric
unit, and 60.5% solvent content).
Data Collection and Structure Determination
Diffraction data were collected at 100 K on beamline
GM/CA-CAT 23-ID-B at the Advanced Photon Source,
Argonne National Laboratory (Argonne, IL). The data were
recorded on a Mar300 detector and processed with HKL2000
(31). Phases were obtained by molecular replacement using
coordinates for the unpublished structure of humanMST (Pro-
tein Data Bank code 3OLH) with the program PHASER (32).
Initial simulated annealing refinement (torsional and cartesian)
was performed for themodel obtained frommolecular replace-
ment with phenix.refine (33) to remove potential model bias.
Subsequently, restrained individual atomic refinement and
restrained isotropic individual B-factor refinement with maxi-
mum likelihood targets using the Babinet model for bulk sol-
vent scaling was performed using REFMAC5 (34) of the CCP4
suite (35). COOT (36) was used to manually correct the incor-
rectly modeled residues, and through successive iterative
rounds of refinement and manual model building, the remain-
ing residues were traced in the electron density to afford the
structural model. In later rounds of refinement, electron den-
sity near the active site was assigned and modeled with 3-MP.
The final 3-MP bound to t-MST model was refined to 2.15 Å
resolution. Crystallographic information as well as refinement
statistics are provided in Table 1. The geometric quality of the
models was assessed with MolProbity (37). PyMOL (38) was
used to create molecular images.
RESULTS
Expression and Purification of MST—The human MST
cDNA lacking 10 and 8 amino acids from the N and C termini,
respectively, was cloned into the pET28b vector with an N-ter-
minal six-histidine tag. The N-terminal residues were removed
because they are predicted to represent the mitochondrial tar-
geting sequence, whereas eight C-terminal residues were elim-
inated because they are predicted to be disordered. The yield of
MST was 12 mg liter1 of E. coli culture, and the protein was
judged to be95% pure based on SDS-PAGE analysis (Fig. 2a).
This protein was used in the kinetic studies described below.
MST migrated as a monomer by gel filtration chromatography
Structural Enzymology of MST
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on a Superdex 200 column and eluted with an apparent molec-
ular mass of 34 kDa (not shown), consistent with the protein
being a monomer. The exact molecular mass of the purified
protein was determined by electrospray ionization mass spec-
trometry to be 33,455Da (Fig. 2b) in good correspondence with
the predicted molecular mass of 33,549 Da.
pH Dependence of MST Activity—In the literature, MST
activity has often been measured at high pH (21, 39), making it
difficult to evaluate the physiological significance of the
reported kinetic data. The effect of pH on humanMST activity
was therefore determined in the lead sulfide assay in the pres-
ence of 2-mercaptoethanol as reductant and over a pH range of
4.5–10.5. MST exhibits a bell-shaped dependence on pHwith a
maximum at 8.21 	 0.03 and inflection points at 7.2 and 9.2,
respectively (Fig. 2c).
Kinetics of H2S Generation with Small Molecule Reductants—
The kinetic parameters associated with H2S generation from
3-MP were determined in the presence of various small mole-
cule acceptors including four physiologically relevant (DHLA,
L-cysteine, L-homocysteine, and GSH) and two nonphysiologi-
cal (2-mercaptoethanol andDTT) reductants (Table 2). TheKm
value for each reductant was separately determined at a satu-
rating concentration of 3-MP (Table 2). Although a hyperbolic
dependence of the reaction rate on the concentrations of DTT
and DHLA was observed, a sigmoidal dependence was seen
with the monothiols, 2-mercaptoethanol, cysteine, homocys-
teine, and GSH (Fig. 3). The Km values for DTT, DHLA, and
cysteine, were 4 mM, and higher values were obtained for
homocysteine (12.5	 1mM), GSH (28	 2mM), and 2-mercap-
toethanol (108 	 16 mM).
The dependence of reaction rate on 3-MP concentration at
saturating concentrations of the reductants revealed distinctly
sigmoidal kinetics with homocysteine and cysteine (Fig. 4). The
Km values for 3-MP were estimated at saturating concentra-
tions of each acceptor and were similar for most (ranging from
20 to 30 M) with the exception of the reaction with 2-mercap-
toethanol (130 	 30 M), which yielded a significantly higher
value. TheVmax for H2S generation clustered in the 0.61	 0.04
to 11	 2molmin1mg1 protein range for all reductants but
was considerably higher in the presence of 2-mercaptoethanol
(417 	 38 mol min1 mg1 protein). The kcat/Km varied over
a 200-fold range with 2-mercaptoethanol and DTT being the
most proficient and GSH being the least proficient (Table 2).
H2S Generation in the Presence of Thioredoxin—As shown in
Fig. 1c, MST can be coupled to the thioredoxin/thioredoxin
reductase/NADPH system for transfer and subsequent reduc-
tion of persulfide to H2S. We have determined the kinetic
parameters for H2S generation by this system using the human
proteins (Fig. 5). From the change in absorbance at 340 nm
associated with oxidation of NADPH, the Km values for thiore-
doxin (Fig. 5a) and 3-MP (Fig. 5b) were estimated to be 2.5 	
0.4 and 393 	 26 M, respectively (Table 2). The Vmax for
NADPHoxidationwas 2.3	 0.2molmin1mg1 protein. To
verify that H2S was indeed being generated in this reaction, its
production was monitored directly in the lead acetate assay as
described under “Experimental Procedures.” Under these con-
ditions, the Vmax for H2S formation was 2.4 	 0.2 mol min1
mg1 protein. The kcat/Km for H2S production in the presence
of thioredoxin (520 mM1 s1) was 400- and 250-fold higher
than the most efficient nonphysiological reductants, DTT and
-mercaptoethanol, and 1,300–52,000-fold higher than the
small molecule biological reductants (Table 2).
TABLE 1
Data Collection and Refinement Statistics (Molecular Replacement)
Protein MST
Data Collection
Space group C2
Cell dimensions
a, b, c (Å) 110.7, 171.9, 73.0
, ,  (°) 90, 117.2, 90
Wavelength (Å) 1.033
Resolution (Å) 50–2.16 (2.23–2.16)
Rsym (%) 7.4 (50.3)
I/I 6.8 (1.7)
Completeness (%) 96.1 (76.4)
Redundancy 1.8 (1.7)
Refinement
Resolution (Å) 85.9–2.16
No. reflections 58794
Rwork/Rfree 0.185/0.220
No. atoms
Protein 6620
Water 352
Pyruvate 18
B-factors
Protein 32.4
Water 35.9
Pyruvate 31.4
Root mean square deviations
Bond lengths (Å) 0.011
Bond angles (°) 1.384
Ramachandran plot (%)
Favored/allowed/outliers 97.0/3.0/0.0
Clashscore, all atoms 2.3
MolProbity score 1.29
Protein Data Bank code 4JGT
FIGURE 2. Characterization of MST. a, 10% SDS-polyacrylamide gel of puri-
fied recombinant human mercaptopyruvate sulfurtransferase. b, intact mass
estimation of pure MST by electrospray ionization mass spectrometry. c,
dependence of MST activity on pH. The buffers used in the different pH
ranges were: citrate (pH 4.5– 6.5), HEPES (pH 6.5– 8.3), and borate (pH
8.2–10.5).
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Kinetics of CyanideDetoxification—One role long ascribed to
MST is cyanide detoxification. The kinetic parameters for sul-
fur transfer to cyanide to form thiocyanate were assessed in the
presence of 3-MP (Fig. 6). The estimated Vmax for this reaction
was 4.3 	 0.3 mol min1 mg1 protein, and the Km values for
KCN and 3-MP were 6 	 1 mM and 350 	 62 M, respectively
(Table 2).
Crystal Structure of the MST3-MP Complex—The crystal
structure of 3-MP bound to MST was solved at 2.15 Å resolu-
tion (Fig. 7a). The MST structure is comprised of two domains
with a classical rhodanese-like fold: anN-terminal domain (res-
idues 1–138, shown in blue in Fig. 7a), and aC-terminal domain
(residues 165–285, shown in lavender), connected by a long
linker (residues 139–164 shown inmagenta) that wraps around
and interacts tightly with both domains. A cleft located
between the two rhodanese-like domains houses the active site
(Fig. 7b). Both domains contribute residues that line the active
site, and 3-MP binds in the cleft between them. The overall
structure of 3-MP bound to MST is very similar to that of
ligand-free MST (Protein Data Bank code 3OLH) (root mean
square deviation of 0.38 Å based on all C atoms), indicating
that 3-MP binding is not accompanied by large structural rear-
rangements (Fig. 7c).
Interactions in the Active Site—Clear electron density is
observed in the active site in the vicinity of Cys248 (Fig. 8a). We
attempted to model two different sets of chemically plausible
structures in the MST active site: a persulfide (Cys248-S-SH)
TABLE 2
Summary of kinetic parameters of human MST
Acceptor Km Aa Km 3-MPb Vmax kcat kcat/Km A
mM M mol min1 mg1 s1 mM1 s1
2-Mercaptoethanol 108 	 16 130 	 30 417 	 38 229 2.1
DTT 4.6 	 0.5 26 	 5 11 	 2 6.1 1.3
Cyanide 6 	 1 350 	 62 4.3 	 0.3 2.4 0.4
Dihydrolipoic acid 4.4 	 0.3 25 	 6 3.1 	 0.3 1.7 0.39
L-Cysteine 4.1 	 0.6 22 	 2 2.0 	 0.2 1.1 0.27
L-Homocysteine 12.5 	 1.6 30 	 0.2 1.6 	 0.2 0.8 0.06
Glutathione 28 	 2 20 	 0.4 0.61 	 0.04 0.3 0.01
Thioredoxin 2.5 	 0.4  103 350 	 62 2.3 	 0.2 1.3 520
a The Km values are for the acceptors (A) shown in the first column.
b The Km values were determined for mercaptopyruvate (3-MP) in the presence of the acceptors shown in the first column.
FIGURE 3. Kinetics of H2S generation by MST in the presence of varying
concentrations of small molecule acceptors. The reaction mixtures con-
tained 0 –300 mM 2-mercaptoethanol (a), 0 –20 mM dithiothreitol (b), 0 –20
mM DHLA (c), 0 –14 mM L-cysteine (d), 0 –70 mM L-homocysteine (e), or 0 –100
mM L-GSH (f) in 200 mM of HEPES, pH 7.4, 0.3 or 0.5 mM 3-MP, 0.1 mg/ml BSA,
and 0.4 mM lead nitrate as described under “Experimental Procedures.” The
data are representative of a minimum of two independent data sets.
FIGURE 4. Kinetics of H2S generation by MST in the presence of varying
concentrations of 3-MP. The reaction mixtures contained: 50 mM -mercap-
toethanol (a), 25 mM DTT (b), 25 mM DHLA (c), 20 mM L-cysteine (d), L-homo-
cysteine (e), or 30 mM GSH (f) in 0 –175 M 3-MP and 200 mM of HEPES, pH 7.4,
containing BSA (0.1 mg/ml) and lead nitrate (0.4 mM). Each panel is represent-
ative of a minimum of two independent data sets.
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plus pyruvate and a mixed disulfide between 3-MP and Cys248
(Cys248-S-SR).Wewere unable to unequivocally distinguish the
two complexes from one another based on the active site elec-
tron density. Both MSTintermediate/product complexes were
modeled and refined separately. The refinement statistics and
fit to the electron density are slightly better for a persulfide
(Cys248) plus pyruvate product complex (Fig. 8, b and c). Based
on our results, we cannot exclude the possibility that we have a
mixed population of both species in the active site. In both
complexes, the positions of the carboxyl and carbonyl groups in
3-MP or pyruvate are indistinguishable. The main difference
between the two models is in the position of the C3 methylene
group of 3-MP or the equivalent C3 methyl group in pyruvate.
We use themodel of the persulfide plus pyruvate product com-
plex (Fig. 8c) to describe the interactions in the active site in the
next section.
An extensive hydrogen-bonding network is present between
pyruvate and MST that includes Arg188 and Arg197, which
hydrogen bond with the carboxyl group of pyruvate. Arg197 is
also engaged in a hydrogen bond interaction with the carbonyl
group of pyruvate. These two arginine residues were previously
predicted to be important for substrate interactions (28, 40). In
addition, Tyr108 andThr253 formwater-mediated contacts with
an oxygen atom of the carboxylate group in pyruvate. Ser250
forms a hydrogen bonding interaction with the pyruvate car-
bonyl group. Previous work on MST from Leishmania major
(40) suggested that MST contains a serine protease-like cata-
lytic triad, predicted to comprise Ser250-His74-Asp63 in the
human sequence. Our structure supports this prediction, with
His74 hydrogen-bonded to Ser250 and Asp63 hydrogen-bonded
to His74 (Fig. 8c). The C-terminal domain donates residues that
make polar contacts with pyruvate such as Arg188, Arg197,
Ser250, and Cys248. The methyl group of the pyruvate faces a
region lined by Trp36 and Tyr108 that reside in the N-terminal
domain of MST. The N-terminal domain also donates two of
the catalytic triad residues, Asp63 and His74.
Structural Comparison of MST3-MP and Rhodanese—MST
is a member of the rhodanese/Cdc24 protein phosphatase
superfamily. Superimposition of the substrate-bound MST
(blue) and its closest structural homolog based on a Dali
search, bovine rhodanese (Protein Data Bank code 1DP2;
yellow), is shown in Fig. 9. The nucleophilic active site cys-
teine is conserved in rhodanese, whereas Arg197 and Ser250 in
MST are replaced by an aspartate and a lysine, respectively,
in rhodanese.
DISCUSSION
3-MP, derived from cysteine via a transamination reaction,
is an intermediate in the cysteine catabolism pathway (Fig.
1). The sulfur atom of 3-MP can be transferred via MST to
various thiophilic acceptors. The presence of MST variants
fused to thioredoxin in some protozoan parasites (23, 26)
strongly suggests that thioredoxin is a physiological persul-
fide acceptor, and indeed, rat MST has been shown to couple
to it (25). More recently, DHLA has been added to the list of
potential physiological acceptors of MST, whereas cysteine
and GSH were reportedly unable to couple to MST (19). In
this study, we have determined the kinetic properties of
humanMST using highly pure enzyme and assessed its reac-
tivity with a range of acceptors. Together with the first crys-
tal structure of MST with bound substrate/product, our
study provides insights into the reaction mechanism of this
relatively poorly characterized H2S generator and lays the
FIGURE 5. Kinetics of H2S generation by MST in the presence of thiore-
doxin. a, the dependence of the MST reaction on thioredoxin (0 –7 M) con-
centration was determined as described under “Experimental Procedures.” b,
the dependence of the MST reaction on 3-MP in the presence of 3.5 M
thioredoxin reductase and 20 M thioredoxin was determined as described
under “Experimental Procedures.” The data are representative of a minimum
of two independent data sets.
FIGURE 6. Kinetics of thiocyanate formation by MST. The dependence of
the MST reaction on potassium cyanide concentration (a, 0 –25 mM) and the
dependence of the MST-catalyzed thiocyanate formation in the presence of
3-MP (b, 0 –2 mM) were determined as described under “Experimental Proce-
dures.” The data are representative of a minimum of two independent data
sets.
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foundation for comparative analysis of the relative contribu-
tions of MST versus cystathione -synthase and -cystathio-
nase to H2S biogenesis.
KineticAnalysisHumanMST—MSTcancouple tobothmono-
thiols (2-mercaptoethanol,GSH, cysteine, andhomocysteine) and
dithiols (DTT, thioredoxin, and DHLA) for sulfur transfer from
FIGURE 7. Structure of human MST. a, crystal structure of MST displayed in a ribbon drawing (N-terminal domain shown in blue; C-terminal domain
shown in lavender; linker region between the two domains shown in magenta). The persulfide and pyruvate product as well as residues lining the active
site are displayed as sticks. b, space filling model of MST with active site products persulfide and pyruvate shown as yellow spheres. c, superimposition
of C atoms of the persulfide pyruvate-bound MST (blue) with ligand-free MST (Protein Data Bank code 3OLH; yellow). Active site residues are shown in
stick display.
FIGURE 8. Close-up of the active site of human MST. a, unbiased experimental electron density in the MST active site based on a composite omit map.
The green contours at 1  represent electron density at the active site prior to modeling and refinement of any substrates or products. The light blue
contours at 1  represent unbiased electron density of selected active side residues. b, refined electron density (weighted 2Fo  Fc) with 3-MP in the
active site contoured at 1  and shown in light blue. c, refined electron density (weighted 2Fo  Fc) with pyruvate and a persulfide in the active site
contoured at 1  and shown in light blue. d, important active site residues and their interactions with pyruvate and persuldide are highlighted into two
views of the active site.
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3-MP (Figs. 3–5). In these reactions, H2S is eliminated following
persulfide transfer as described by Reactions 1–3.
MST-SH  3-MP ¡ MST-S-SH  pyruvate
MST-S-SH  R-SH ¡ MST-SH  R-S-SH
R-S-SH  RSH ¡ R-S-S-R  H2S
REACTIONS 1–3
The steady-state kinetic analysis shows a hyperbolic depend-
ence of the reaction rate of H2S production on dithiol acceptor
concentration. In contrast, the kinetics are clearly sigmoidal in
the presence of monothiols (Figs. 3 and 4). Although a single
equivalent of dithiol is sufficient for the liberation of H2S from
the transferred persulfide (Fig. 1c), two equivalents ofmonothi-
ols are needed per transferred persulfide (Reactions 2 and 3).
Based on kcat/Km values, a 52,000-fold range in efficacy of H2S
production from 3-MP is observed in the presence of the vari-
ous acceptors (Table 2). Of the physiological acceptors, thiore-
doxin is themost efficient (520mM1 s1), andGSH is the least
(0.01 mM1 s1). DHLA, cysteine, and homocysteine are
intermediate, being 1,000–9,000-fold less efficient than
thioredoxin.
A previous study with extracts from human lung adenocar-
cinoma cells (A549) failed to detect H2S production in the pres-
ence of 1 mM cysteine or GSH (19). This discrepancy between
our results is likely due to the use in the previous study of crude
cell extracts in which other enzymes that could compete for the
utilization of the thiols were present combined with the high
Km values for cysteine (4.1	 0.6mM) and GSH (28	 2mM) for
MST-dependent H2S production (Table 2). The Km for DHLA
is also high (4.4 	 0.3 mM) compared with its reported physio-
logical concentration (4–10 M in murine tissues (41). How-
ever, much of the DHLA pool is covalently bound to proteins,
and exogenous DHLA added to cell extracts would not have
competed for these binding sites and therefore been available
for the MST reaction in the cell extract assay. DHLA is a deriv-
ative of the hydrophobic octanoic acid and is unlikely to readily
couple to soluble proteins like MST. In contrast to DHLA, the
Km for human thioredoxin is low (2.5 	 0.4  103 mM) and in
the concentration range found in cells (20 M) (42). On the
other hand, the high Km for 3-MP in the thioredoxin-depen-
dent reaction is high (350 	 62 M) relative to the Km values in
the presence of other biotic thiol acceptors (20–30 M) and
raises questions about the relevance of thioredoxin-dependent
H2S production by MST. The relative concentrations of each
acceptor in the compartments where MST functions, together
with theirKm values, will determine their relative importance in
coupling to MST for H2S biogenesis in the cellular milieu.
Proposed Reaction Mechanism for MST Based on the
MST3MP Structure—Our structure of MST with pyruvate or
3-MP bound provides rich insights into interactions between
the substrate and active site residues. Two basic residues,
Arg188 and Arg197 engage in electrostatic interactions with the
carboxyl and carbonyl groups of pyruvate (Fig. 8). Mutations of
the corresponding arginines in rat MST result in 10-fold
(R196G) and 60-fold (R187G) increases in theKm for 3-MP (28).
In the structures of the E. coli and L. majorMSTs, a persulfide
intermediate stabilized via hydrogen bonds withmultiple back-
bone amides was seen (27, 40). The nucleophilic cysteine in
MST needs to be activated to initiate the sulfur transfer reac-
tion. Mutation of the corresponding cysteine residue in rat
MST results in no detectable sulfurtransferase activity (28). A
catalytic triad first observed in the L. majorMST (40) compris-
ing residues Ser250, His74, and Asp63 in human MST could be
involved in activating Cys248. In serine proteases, the histidine
and aspartate residues lower the pKa of the serine hydroxyl
moiety, thereby activating it for covalent catalysis. We propose
that in humanMST, His74 could abstract a proton from Ser250,
which in turn activates the Cys248 thiol for attack on the sub-
FIGURE 9. Structural comparison of rhodanese and MST. a, superimposition of structures based on C traces of the 3-MP-bound MST and bovine rhodanese
(Protein Data Bank code 1DP2). The structures are displayed as ribbon drawings with MST in blue and rhodanese shown in yellow. Active site residues are shown
in stick display. b, close-up view of the active sites of MST and rhodanese.
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strate thiol (Fig 10, step 1), leading to formation of an enzyme-
bound persulfide and pyruvate anion (2). The resulting oxyan-
ion intermediate could be stabilized via interactions with the
hydroxyl group of Ser250, the side chain of Arg197, and by the
positive electrostatic potential in theMST active site.Mutation
of the corresponding serine residue in rat MST has a modest
10-fold effect on kcat without affecting the Km for 3-MP.
Hence, other strategies for enhancing the reactivity of Cys248
must be deployed and could include orientation of -helix
dipoles (residues 253–264 and 276–283) in theMST active site
(40). An alternative role has been postulated for the catalytic
triad, i.e. in electrophilic catalysis via activation of the serine
residue, which then polarizes the carbonyl group of 3-MP pro-
moting attack by the nucleophilic cysteine (40).
Tautomerization and release of pyruvate followed by binding
of an acceptorwould initiate the secondhalf-reaction, i.e. trans-
fer of the sulfane sulfur and regeneration of the active site cys-
teine thiol (step 2). In this step, the His74–Ser250 dyad could be
involved in acid-base catalysis, protonating the methylene
group in the enolate tautomer of pyruvate prior to its departure
from the active site. Our crystal structure with the Cys248 per-
sulfide and pyruvate represents a product complex formed at
the end of the first half-reaction. Transfer of the sulfane sulfur
from the persulfide to an acceptor completes the second half-
reaction (step 3). In the crystal structure of MST with pyruvate
bound, the hydroxyl group of serine is too far from the Cys248
thiol to serve as a general base. It is possible that as the reaction
progresses, the Ser250 hydroxyl is oriented away from Cys248
and toward the carbonyl group of 3-MP, stabilizing the nascent
negative charge in the transition state.
Based on the proposed reaction mechanism, how can the
presence of a mixed disulfide intermediate between Cys248 and
3-MP be explained? Amixed disulfide intermediate formed via
oxidative addition of the active site cysteine and 3-MP has been
proposed for MST (27). However, this mechanism seems
unlikely because theMST reaction does not require a two-elec-
tron acceptor. Instead, formation of the mixed disulfide mod-
eled in the crystal structure might be accounted for as follows.
In the second half-reaction catalyzed by MST, the catalytic
triad is postulated to activate the substrate thiol for nucleo-
philic attack on the sulfane sulfur on Cys248 (Fig. 11a). Consist-
ent with thismodel, the hydroxyl group of Ser250 is closer to the
sulfur on 3-MP (4.1Å) than to the sulfur onCys248 (5.5Å). Thiol
activation sets up a sulfur transfer reaction from the enzyme to
FIGURE 10. Postulated reaction mechanism of MST. Two arginine residues (Arg188 and Arg197) anchor the substrate carboxylate and carbonyl groups,
whereas the catalytic triad (Asp63-His74-Ser250) in MST is postulated to activate Cys248 (step 1) for nucleophile attack on 3-MP (red) to give an enzyme bound
persulfide. Release of the pyruvate anion following release and binding of the sulfur acceptor (step 2) set up the second half-reaction. Nucleophilic attack of the
acceptor (a small molecule (di)thiol or thioredoxin) on the sulfane sulfur results in formation of the product persulfide, which is released (step 3) to complete the
catalytic cycle. For clarity, not all interactions between the hydroxyl group of Ser250 and the substrate discussed in the text or the other steps in which
the catalytic triad might participate in acid-base catalysis are shown.
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the acceptor and regenerates the resting formofMST.An alter-
native and presumably side reaction occurs when the catalytic
triad activates the MST-bound persulfide instead, setting up a
nucleophilic attack on the C-3 methylene carbon of 3-MP and
eliminating H2S (Fig. 11b). The disulfide could undergo a sec-
ond round of sulfur transfer in the presence of a small molecule
acceptor to regenerate resting enzyme. Controlling the orien-
tation of the Ser250 hydroxyl group thus might be critical for
ensuring the fidelity of the reaction in the first and second half-
reactions. Mutation of Ser250 might lead to a change in the
identity and distribution of products and warrants evaluation.
It is possible that the low pH and temperature conditions
used for crystallization promoted capture of the disulfide inter-
mediate formed in a side reaction. Nevertheless, the structure
FIGURE 11. Mechanism of sulfur transfer from the persulfide intermediate in MST and a side reaction with the sulfur acceptor. a, the catalytic triad is
postulated to play a role in activating Ser250 during transfer of the MST-bound persulfide to an acceptor depicted here as 3-MP. b, the structure of the mixed
disulfide seen in the crystal structure of 3-MST could arise from adventitious activation of the sulfane sulfur by Ser250, resulting in it attacking the C-3 methylene
carbon of 3-MP. The products of this reaction are H2S and an enzyme-bound mixed disulfide between Cys
248 and substrate.
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provides valuable insights into interactions between pyruvate/
3-MP and residues lining theMST active site. 3-MP is known to
function as both a sulfur donor and an acceptor (10). Interest-
ingly, attack of the cysteine thiolate on themethylene carbon of
3-cholorpyruvate, a stoichiometric inhibitor of MST, has been
observed and generates a covalent adduct (43). This is similar to
the postulated attack of the persulfide on the C-3 carbon of
3-MP to generate the observedmixed disulfide seen in the crys-
tal structure (Fig. 11b) and further reinforces the importance of
controlling reactivity and orientation of active site residues to
promote the desired reaction while suppressing unwanted side
reactions, exemplifying the principle of negative catalysis (44).
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